GS JT (Votrient pazopanib 200 mg)
Generic Name: pazopanib
Pill imprint GS JT has been identified as Votrient pazopanib 200 mg.
Votrient is used in the treatment of renal cell carcinoma; soft tissue sarcoma and belongs to the drug class VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Votrient pazopanib 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for GS JT (Votrient pazopanib 200 mg)
Votrient
- Generic Name:
- pazopanib
- Imprint:
-
GS JT
- Strength:
- pazopanib 200 mg
- Color:
- Gray
- Size:
- 14.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- VEGF/VEGFR inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00173-0804
- Inactive Ingredients:
- magnesium stearate
microcrystalline cellulose
povidone
sodium starch glycolate type A potato
hypromellose
ferric oxide black
polyethylene glycol 400
polysorbate 80
titanium dioxide
More resources
Votrient is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
